Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by danso on Friday June 11, 2021 @01:04PM (#27475833)

Sorry, I didn't say you can't consider Aduhelm to be an herbal supplement, just that every premise and factor in the current discussion would be rendered irrelevant.

So OK, let's agree that Aduhelm is now an herbal supplement. The FDA no longer has the authority to ban it from Walgreens. What's your point? The FDA's decision is about Aduhelm's proven effectiveness as a drug, and it has no bearing on whether Biogen wants to sell it as OTC herbal supplement. Do you believe the FDA is what's preventing Biogen from doing that right now?

[ Parent | on HN ]

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by bitshiftfaced on Friday June 11, 2021 @01:25PM (#27476091)

The OP was saying how by allowing the accelerated approval, the FDA failed to protect people from a drug that hasn't yet been shown to be effective. My point was that it's not like the FDA protects people from snake oil anyway. Doctors can already get their patients to spend tons of money on unproven treatments. As long as the treatment isn't lying about what the evidence has shown, adults and their doctors are able to make decisions based on available information, and generally society is ok with that. That sentiment conflicts with OP's sentiment. That is why the comparison is relevant to the discussion.

[ Parent | on HN ]